An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Phase of Trial: Phase I
Latest Information Update: 09 Aug 2018
At a glance
- Drugs Dupilumab (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- Sponsors Regeneron Pharmaceuticals
- 30 Jul 2018 Status changed from active, no longer recruiting to completed.
- 31 Oct 2017 Status changed from recruiting to active, no longer recruiting.
- 30 Apr 2017 Status changed from not yet recruiting to recruiting.